( 03613.hk) | 15.05 | 1.43 | 5.60% (5.60%) | 上市时间2013-05-07股价7.14港币涨跌幅0.56%成交金额434.17万港币换手率0.07%市值59.77亿港币H股市值59.77亿港币总股本8.37亿H股本8.37亿每手股数1,000上市至今年化投资收益率3.09%港股通持仓占H股比例19.49% (11.73亿港币2026-05-20) 累计做空占H股比例2.15% (1.32亿港币2026-05-15) | |||
| 所属三级行业中医药 (恒生) | 市盈率 | 10.94 | 市净率 | 0.62 | 股息率 | 5.13% (4.80%) | 恒生:医疗保健业药品及生物科技中医药 |
| 所属指数指数纳入纳出 | |||||||
| 备注 (15): | 双击编辑备注 |
同仁堂国药(03613) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 顧海鷗 | Executive Director | Chairman | 2023-12-13 | -- |
| 2 | 余勁 | Executive Director | CEO | 2023-10-20 | -- |
| 3 | 馮莉 | Non Executive Director | 2023-03-13 | -- | |
| 4 | 徐宏喜 | Independent Non Executive Director | 2023-03-13 | -- | |
| 5 | 馮莉 | Executive Director | 2022-08-12 | 2023-03-13 | |
| 6 | 陳飛 | Executive Director | 2021-03-11 | -- | |
| 7 | 陳飛 | Non Executive Director | 2020-03-24 | 2021-03-11 | |
| 8 | 曾鈺成 | Independent Non Executive Director | 2017-09-12 | -- | |
| 9 | 梅群 | Non Executive Director | 2014-05-07 | 2019-03-11 | |
| 10 | 陳毅馳 | Independent Non Executive Director - A/F | 2013-04-15 | -- | |
| 11 | 趙中振 | Independent Non Executive Director | 2013-04-15 | 2023-03-13 | |
| 12 | 林曼 | Executive Director | 2011-02-01 | 2023-09-12 | |
| 13 | 張煥平 | Executive Director | CEO | 2011-02-01 | 2021-03-11 |
| 14 | 丁永玲 | Executive Director | Chairman | 2004-09-28 | 2023-08-31 |